L250-1112 Screening compound: N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide

L250-1112 Screening compound: N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide
L250-1112 Screening compound: N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L250-1112
N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L250-1112

Molecular Formula

C29H38N4O3 (C29 H38 N4 O3)

Compound Name

N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide

IUPAC name

N-[3-(diethylamino)propyl]-2-[1-(2-phenyl-13-benzoxazole-6-carbonyl)piperidin-4-yl]propanamide

SMILES

CCN(CC)CCCNC(C(C)C(CC1)CCN1C(c(cc1)cc2c1nc(-c1ccccc1)o2)=O)=O

InChI

InChI=1S/C29H38N4O3/c1-4-32(5-2)17-9-16-30-27(34)21(3)22-14-18-33(19-15-22)29(35)24-12-13-25-26(20-24)36-28(31-25)23-10-7-6-8-11-23/h6-8,10-13,20-22H,4-5,9,14-19H2,1-3H3,(H,30,34)/t21-/m0/s1

InChI Key

SCMKKIGOEIIXPL-NRFANRHFSA-N

MDL Number (MFCD)

MFCD15120957

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.65

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.669

Distribution Coefficient, logD

0.890

Water Solubility, LogSw

-3.73

Polar Surface Area

61.635

Acid Dissociation Constant (pKa)

15.07

Base Dissociation Constant (pKb)

10.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.30

L250-1112 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L250-1112 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L250-1112?
Check Price and Availability of L250-1112, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L250-1112 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L250-1112
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L250-1112
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L250-1112 available by request